| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017464954 |
| P356 | DOI | 10.1186/S12931-015-0219-1 |
| P932 | PMC publication ID | 4451749 |
| P698 | PubMed publication ID | 26018813 |
| P5875 | ResearchGate publication ID | 277410229 |
| P2093 | author name string | Neil Patel | |
| Monica A Spiteri | |||
| Nicholas R Forsyth | |||
| John Belcher | |||
| Gary Thorpe | |||
| P2860 | cites work | Local inflammation occurs before systemic inflammation in patients with COPD | Q83153205 |
| Chronic Obstructive Pulmonary Disease Patients' Experiences of an Enhanced Self-Management Model of Care | Q86822722 | ||
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 | ||
| The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions | Q24628711 | ||
| Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis | Q27488135 | ||
| Salivary eicosanoid concentration in patients with Sjögren's syndrome | Q33578828 | ||
| Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles | Q33639706 | ||
| Current developments in salivary diagnostics. | Q33803001 | ||
| Salivary proteomics for oral cancer biomarker discovery | Q33879157 | ||
| Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. | Q33996036 | ||
| Development of transcriptomic biomarker signature in human saliva to detect lung cancer | Q34000934 | ||
| Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry | Q34077576 | ||
| Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD. | Q34193763 | ||
| One-step homogeneous C-reactive protein assay for saliva | Q34206306 | ||
| Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. | Q34301553 | ||
| Compartment differences of inflammatory activity in chronic obstructive pulmonary disease | Q34570194 | ||
| Saliva: diagnostics and therapeutic perspectives | Q34669417 | ||
| The diagnostic applications of saliva--a review | Q34720733 | ||
| Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease | Q34721302 | ||
| Salivary diagnosis: more than a lick and a promise | Q34730584 | ||
| Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency | Q34992288 | ||
| Utility of the CAT in the therapy assessment of COPD exacerbations in China | Q35117371 | ||
| Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations | Q35535368 | ||
| Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | Q35536791 | ||
| Raised CRP levels mark metabolic and functional impairment in advanced COPD. | Q36148662 | ||
| C-reactive protein in patients with COPD, control smokers and non-smokers | Q36148673 | ||
| Pulmonary biomarkers in chronic obstructive pulmonary disease. | Q36429908 | ||
| COPD and disease-specific health status in a working population | Q36921848 | ||
| Outcomes for COPD pharmacological trials: from lung function to biomarkers. | Q37073253 | ||
| Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. | Q38061504 | ||
| Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT). | Q38132541 | ||
| Pulmonary biomarkers in COPD exacerbations: a systematic review | Q38154291 | ||
| Evaluation of saliva collection devices for the analysis of proteins | Q39642683 | ||
| The interrelationship of sputum inflammatory markers in patients with chronic bronchitis | Q40798956 | ||
| Validation and quality control of ELISAs for the use with human saliva samples | Q43420704 | ||
| Inflammatory response in acute viral exacerbations of COPD. | Q43468916 | ||
| C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection | Q43938873 | ||
| The diurnal patterns of salivary interleukin-6 and C-reactive protein in healthy young adults | Q43970045 | ||
| Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study | Q44204171 | ||
| The neutrophil in chronic obstructive pulmonary disease | Q45342652 | ||
| Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children | Q45743478 | ||
| Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group | Q45880405 | ||
| Human herpesvirus 8 detection in nasal secretions and saliva | Q46110333 | ||
| Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma. | Q46403708 | ||
| Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease | Q47863660 | ||
| Aα-Val360: a marker of neutrophil elastase and COPD disease activity | Q47871052 | ||
| Transient elevation of neutrophil proteinases in induced sputum during COPD exacerbation | Q47980995 | ||
| Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. | Q48461345 | ||
| The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients. | Q48896009 | ||
| Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. | Q50857136 | ||
| Validation of a high-sensitivity assay for C-reactive protein in human saliva. | Q51891330 | ||
| Interrelationship between serum and sputum inflammatory mediators in chronic obstructive pulmonary disease. | Q53493698 | ||
| Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD | Q57759362 | ||
| Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis | Q61162701 | ||
| Increased neutrophil elastase activity in cigarette smokers | Q68830386 | ||
| A newly developed PCR assay of H. pylori in gastric biopsy, saliva, and feces. Evidence of high prevalence of H. pylori in saliva supports oral transmission | Q71835003 | ||
| Biochemical composition and electrolyte balance of "unstimulated" whole human saliva | Q74120394 | ||
| Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma | Q74448268 | ||
| Toward molecularly based diagnostics for the oral cavity | Q77137193 | ||
| A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels | Q77922288 | ||
| [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease] | Q77938747 | ||
| Oxidative stress indices in COPD--Broncho-alveolar lavage and salivary analysis | Q79339807 | ||
| Inflammatory changes, recovery and recurrence at COPD exacerbation | Q79362620 | ||
| Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease | Q79786400 | ||
| Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences | Q80498689 | ||
| Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting | Q81269798 | ||
| Salivary procalcitonin and periodontitis in diabetes | Q81508314 | ||
| C-reactive protein levels and clinically important predictive outcomes in stable COPD patients | Q82458910 | ||
| P921 | main subject | saliva | Q155925 |
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 62 | |
| P577 | publication date | 2015-05-28 | |
| P1433 | published in | Respiratory Research | Q7315904 |
| P1476 | title | Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters | |
| P478 | volume | 16 |
| Q47831284 | Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers. |
| Q92292830 | Neutrophil elastase as a biomarker for bacterial infection in COPD |
| Q57167213 | Proteases and Their Inhibitors in Chronic Obstructive Pulmonary Disease |
| Q47238746 | Role of Streptococcus pneumoniae OM001 operon in capsular polysaccharide production, virulence and survival in human saliva. |
| Q59944797 | Salivary C-reactive protein among at-risk adolescents: A methods investigation of out of range immunoassay data |
| Q37612872 | Specific networks of plasma acute phase reactants are associated with the severity of chronic obstructive pulmonary disease: a case-control study |
| Q104464005 | Sputum procalcitonin levels in patients admitted to hospital with acute exacerbations of bronchiectasis |
Search more.